UNSPSC 51314340: Chlorpheniramine/guaifenesin/phenylephrine/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE503. This VA Drug Class (RE503) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT/EXPECTORANT.

UNSPSC 51314340 Chlorpheniramine/guaifenesin/phenylephrine/phenylpropanolamine is a Commodity code, but the recent state and local opportunities on file show no direct procurement activity for this specific pharmaceutical combination. The three most recent opportunities tagged to this code are actually soliciting naloxone and drug deactivation systems (Seminole County, Florida); direct-to-manufacturer prescription program vendor capabilities (Texas Health and Human Services Commission); and generic multi-source pharmaceuticals and OTC products through a cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations target the chlorpheniramine/guaifenesin/phenylephrine/phenylpropanolamine combination explicitly, and the code appears to have little relevant recent activity at the state and local level.

The mismatch between the code's nominal scope and current opportunities suggests that state and local procurement offices are tagging pharmaceutical solicitations broadly across UNSPSC codes without precision at the specific active-ingredient level. If your firm supplies this particular drug combination to state and local health departments, community health systems, or emergency medical services, monitor cooperative purchasing vehicles such as MMCAP and direct solicitations from county health departments; however, this code should not be your primary search vector. Pursue opportunities through broader pharmaceutical commodity codes, state health department standing contracts, or direct outreach to Seminole County and similar regional health agencies that manage stockpiles of respiratory or allergy medications.